An obstructive sleep apnea primer

Pasha, Sara; Kumar, Sandhya; Chatterjee, Arjun B.; Krishnaswamy, Guha

doi:10.1016/j.anai.2016.07.033

Cited by 5 publications

(2 citation statements)

References 73 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Histamine plays a role in the regulation of the sleep‐wake cycle and arousal, and cysteinyl leukotrienes are involved in sleep disruption 3319,3320 . Excessive histamine results in insomnia and inadequate amounts cause hypersomnolence 3319,3321 . Cytokines released in AR patients, such as IL‐1β and IL‐4, are thought to reduce sleep onset latency and increase the time to onset of rapid eye movement (REM) sleep 1113,3322,3323 .…”

Section: Associated Conditionsmentioning

confidence: 99%

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

106

View full text Add to dashboard Cite

Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document. Methods ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

show abstract

Section: Associated Conditionsmentioning

confidence: 99%

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise

Damask

Roland

et al. 2023

Int Forum Allergy Rhinol

106

View full text Add to dashboard Cite

show abstract

“…Одним из объяснений этой взаимосвязи может быть ассоциация ожирения с хроническим субклиническим воспалением, об "объединяющей" роли которого упоминалось выше. Воспаление предрасполагает людей к СОАС, а СОАС само по себе является провоспалительным процессом [28], следовательно, избыток массы тела является общим ФР для многих заболеваний и клинических состояний, а контроль массы тела повышает степень контроля заболеваний, ассоциированных с ожирением.…”

Section: снижение качества сна в прогнозе дестабилизации аг и соас на...unclassified

The problem of cross risk of arterial hypertension progression, obstructive sleep apnea syndrome and COVID-19

et al. 2023

View full text Add to dashboard Cite

This review considers the risk factors for arterial hypertension (AH) progression, obstructive sleep apnea syndrome (OSAS) and novel coronavirus infection (COVID-19) as potential variables for the prognostic models of estimating the probability of destabilization of the mentioned conditions. The most published studies consider AH and OSAS as the risk factors influencing the course of COVID-19, while moderate and mild COVID-19 can be destabilizing factor regarding to AH and OSAS. In addition, COVID-19, AH and OSAS are interrelated with sleep quality. The worsening of sleep quality often can be both a consequence of these diseases and a factor aggravating their course, and also can cause the increased vulnerability to acute diseases. An increased body mass index is a universal risk factor for many diseases and clinical conditions, and the monitoring of body mass increases the degree of the control of the diseases associated with obesity. In addition, the worsening of sleep quality can be both a consequence of any of above-mentioned conditions and a factor aggravating their course. Also, a promising direction for improving prognostic models is the analysis of autonomic dysfunction in patients.

show abstract

Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management

2020

View full text Add to dashboard Cite

An obstructive sleep apnea primer

Cited by 5 publications

References 73 publications

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

The problem of cross risk of arterial hypertension progression, obstructive sleep apnea syndrome and COVID-19

Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management

Contact Info

Product

Resources

About